161 related articles for article (PubMed ID: 8930463)
1. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
Montagnino G; Lorca E; Tarantino A; Bencini P; Aroldi A; Cesana B; Braga M; Lonati F; Ponticelli C
Clin Transplant; 1996 Oct; 10(5):461-9. PubMed ID: 8930463
[TBL] [Abstract][Full Text] [Related]
2. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL
Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
[TBL] [Abstract][Full Text] [Related]
4. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
5. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
6. Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy.
Abou Ayache R; Thierry A; Bridoux F; Bauwens M; Belmouaz M; Desport E; Touchard G
Transplant Proc; 2007 Oct; 39(8):2592-4. PubMed ID: 17954185
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients.
Zavos G; Bokos J; Papaconstantinou I; Boletis J; Gazouli M; Kakisis J; Zografidis A; Kostakis A
Artif Organs; 2004 Jun; 28(6):595-9. PubMed ID: 15153155
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence after immunosuppressive treatment following kidney transplantation.
Andrés A
Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
[TBL] [Abstract][Full Text] [Related]
9. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
10. Non-lymphoid cancer after liver transplantation.
Frezza EE; Fung JJ; van Thiel DH
Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
[TBL] [Abstract][Full Text] [Related]
11. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
McGeown MG; Douglas JF; Middleton D
Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
[TBL] [Abstract][Full Text] [Related]
12. Malignancy after kidney transplantation: results of 400 patients from a single center.
Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C
Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
14. Incidence and types of malignancies in renal transplant recipients in Iraq.
Altaee IK; Jaleel NA; Aljubury HM; Alshamaa IA; Gazala S
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):408-14. PubMed ID: 16970265
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Neoplastic complications of transplantation.
Penn I
Semin Respir Infect; 1993 Sep; 8(3):233-9. PubMed ID: 8016484
[TBL] [Abstract][Full Text] [Related]
17. Skin malignancies in renal transplant recipients: a Brazilian center registry.
Falsarella PM; Alves-Filho G; Mazzali M
Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
[TBL] [Abstract][Full Text] [Related]
18. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
20. [Malignant neoplasias in renal transplantation recipients].
Gómez-Roel X; León-Rodríguez E
Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]